Skip to main content
SpringerLink
Log in
Book cover

In Vivo Fluorescence Imaging pp 97–108Cite as

Utilization of Near-Infrared Fluorescent Imaging for Pharmaceutically Relevant Applications

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1444))

Abstract

Optical imaging can be utilized for several pharmaceutical applications involving near-infrared fluorescent (NIRF) dyes or NIRF moiety-containing products. Especially during the early phases of product development, NIRF dyes can be used as surrogates for drugs and optical imaging methods can be utilized to optimize the pharmaceutical product properties based on dye entrapment efficiency, in vitro dye release, cellular uptake, and in vivo biodistribution. Based on in vivo accumulation, product efficacy and toxicity can be evaluated in the early development stage. Compared to visible fluorescent dyes, NIRF offers advantages such as low background from formulation excipients as well as biological components.

In this chapter, the utility of NIRF imaging methods for in vitro characterization (in vitro release and cellular uptake) and in vivo/ex vivo applicability of pharmaceutically relevant products is presented in detail. Specifically, the application of fluorescence imaging to characterize perfluorocarbon-based formulations for dye loading, in vitro release, cellular uptake, and in vivo imaging to assess target accumulation and biodistribution is discussed. These methods are widely applicable to other nanoparticle-based products involved in inflammation/cancer imaging and therapy. Overall, NIRF-based techniques are indispensible because they are relatively easy, fast, and cost effective to characterize and optimize pharmaceutical products at different stages of product development.

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. McClements DJ (2012) Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter 8(6):1719–1729

    Article  CAS  Google Scholar 

  2. Shakeel F, Shafiq S, Haq N, Alanazi FK, Alsarra IA (2012) Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview. Expert Opin Drug Deliv 9(8):953–974

    Article  CAS  PubMed  Google Scholar 

  3. Kotta S, Khan AW, Pramod K, Ansari SH, Sharma RK, Ali J (2012) Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv 9(5):585–598

    Article  CAS  PubMed  Google Scholar 

  4. McClements DJ, Rao J (2011) Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit Rev Food Sci Nutr 51(4):285–330

    Article  CAS  PubMed  Google Scholar 

  5. Rajpoot P, Pathak K, Bali V (2011) Therapeutic applications of nanoemulsion based drug delivery systems: a review of patents in last two decades. Recent Pat Drug Deliv Formul 5(2):163–172

    Article  CAS  PubMed  Google Scholar 

  6. Sarker DK (2005) Engineering of nanoemulsions for drug delivery. Curr Drug Deliv 2(4):297–310

    Article  CAS  PubMed  Google Scholar 

  7. Mitri K, Vauthier C, Huang N, Menas A, Ringard-Lefebvre C, Anselmi C, Stambouli M, Rosilio V, Vachon JJ, Bouchemal K (2012) Scale-up of nanoemulsion produced by emulsification and solvent diffusion. J Pharm Sci 101(11):4240–4247

    Article  CAS  PubMed  Google Scholar 

  8. Muller RH, Harden D, Keck CM (2012) Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug delivery. Drug Dev Ind Pharm 38(4):420–430

    Article  CAS  PubMed  Google Scholar 

  9. Janjic JM, Shao P, Zhang S, Yang X, Patel SK, Bai M (2014) Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties. Biomaterials 35(18):4958–4968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Vasudeva K, Andersen K, Zeyzus-Johns B, Hitchens TK, Patel SK, Balducci A, Janjic JM, Pollock JA (2014) Imaging neuroinflammation in vivo in a neuropathic pain rat model with near-infrared fluorescence and (1)(9)F magnetic resonance. PLoS One 9(2):e90589

    Article  PubMed  PubMed Central  Google Scholar 

  11. Patel SK, Patrick MJ, Pollock JA, Janjic JM (2013) Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemuslions. J Biomed Opt 18(10):101312

    Article  PubMed  PubMed Central  Google Scholar 

  12. Balducci A, Wen Y, Zhang Y, Helfer BM, Hitchens TK, Meng WS, Wesa AK, Janjic JM (2013) A novel probe for the non-invasive detection of tumor-associated inflammation. Oncoimmunology 2(2):e23034

    Article  PubMed  PubMed Central  Google Scholar 

  13. Patel SK, Zhang Y, Pollock JA, Janjic JM (2013) Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study. PLoS One 8(2):e55802

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. O'Hanlon CE, Amede KG, O’Hear MR, Janjic JM (2012) NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging. J Fluor Chem 137:27–33

    Article  PubMed  PubMed Central  Google Scholar 

  15. Stoll G, Basse-Lusebrink T, Weise G, Jakob P (2012) Visualization of inflammation using (19) F-magnetic resonance imaging and perfluorocarbons. Wiley interdiscip Rev Nanomed Nanobiotechnol 4(4):438–447

    Article  CAS  PubMed  Google Scholar 

  16. Kadayakkara DK, Beatty PL, Turner MS, Janjic JM, Ahrens ET, Finn OJ (2010) Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas 39(4):510–515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Weise G, Basse-Luesebrink TC, Wessig C, Jakob PM, Stoll G (2011) In vivo imaging of inflammation in the peripheral nervous system by (19)F MRI. Exp Neurol 229(2):494–501

    Article  CAS  PubMed  Google Scholar 

  18. Janjic JM, Srinivas M, Kadayakkara DK, Ahrens ET (2008) Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. J Am Chem Soc 130(9):2832–2841

    Article  CAS  PubMed  Google Scholar 

  19. Akers WJ, Kim C, Berezin M, Guo K, Fuhrhop R, Lanza GM, Fischer GM, Daltrozzo E, Zumbusch A, Cai X, Wang LV, Achilefu S (2011) Noninvasive photoacoustic and fluorescence sentinel lymph node identification using dye-loaded perfluorocarbon nanoparticles. ACS Nano 5(1):173–182

    Article  CAS  PubMed  Google Scholar 

  20. Rapoport N, Nam KH, Gupta R, Gao Z, Mohan P, Payne A, Todd N, Liu X, Kim T, Shea J, Scaife C, Parker DL, Jeong EK, Kennedy AM (2011) Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release 153(1):4–15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Soman NR, Lanza GM, Heuser JM, Schlesinger PH, Wickline SA (2008) Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides. Nano Lett 8(4):1131–1136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Soman NR, Baldwin SL, Hu G, Marsh JN, Lanza GM, Heuser JE, Arbeit JM, Wickline SA, Schlesinger PH (2009) Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J Clin Invest 119(9):2830–2842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Dewitte H, Geers B, Liang S, Himmelreich U, Demeester J, De Smedt SC, Lentacker I (2013) Design and evaluation of theranostic perfluorocarbon particles for simultaneous antigen-loading and (19)F-MRI tracking of dendritic cells. J Control Release 169(1-2):141–149

    Article  CAS  PubMed  Google Scholar 

  24. Caruthers SD, Cyrus T, Winter PM, Wickline SA, Lanza GM (2009) Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(3):311–323

    Article  CAS  PubMed  Google Scholar 

  25. Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA (2002) Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation 106(22):2842–2847

    Article  CAS  PubMed  Google Scholar 

  26. Ravnikar M, Strukelj B, Obermajer N, Lunder M, Berlec A (2010) Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies and tumor necrosis factor alpha. Appl Environ Microbiol 76(20):6928–6932

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Janjic JM, Berlec A, Bagia C, Liu LS, Jeric I, Gach M, Janjic BM, Strukelj B (2016) NIR and MR imaging supported hydrogel based delivery system for anti-TNF alpha probiotic therapy of IBD. SPIE BiOS, 972309–972309-10

    Google Scholar 

  28. Patel SK, Beano W, Anderson C, Janjic JM (2015) Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. 160 (1): 59–70

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Graduate School of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University, Mellon Hall 415, 600 Forbes Avenue, Pittsburgh, PA, 15282, USA

    Jelena M. Janjic, Sravan Kumar Patel & Christina Bagia

Authors
  1. Jelena M. Janjic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sravan Kumar Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christina Bagia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jelena M. Janjic .

Editor information

Editors and Affiliations

  1. Univ of Pittsburgh, Pittsburgh, Pennsylvania, USA

    Mingfeng Bai

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Janjic, J.M., Patel, S.K., Bagia, C. (2016). Utilization of Near-Infrared Fluorescent Imaging for Pharmaceutically Relevant Applications. In: Bai, M. (eds) In Vivo Fluorescence Imaging. Methods in Molecular Biology, vol 1444. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3721-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3721-9_10

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3719-6

  • Online ISBN: 978-1-4939-3721-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation